MOTS-c
Also known as Mitochondrial ORF of the 12S rRNA type-c
Mitochondrial-derived peptide studied for metabolic health.
- Category
- longevity
- Route
- subq
- Documented dose
- 5000–10000 mcg
- Typical frequency
- 2-3 times weekly
- Cycle
- 4 weeks on, 4 off
- Half-life
- ~30 minutes
- Common vial sizes
- 5 mg, 10 mg
- Regulatory status
- Not approved for human use.
What it does
A peptide coded by mitochondrial DNA rather than the cell nucleus. It behaves like an exercise signal, telling muscle to burn glucose and fat more efficiently. What people look into it for: • Better insulin sensitivity and blood-sugar control • More endurance and exercise capacity — sometimes called an "exercise mimetic" • Fat loss and metabolic flexibility • Healthy-ageing protocols, since natural levels fall with age Most findings so far come from animal studies and small human observations.
Mechanism
Activates AMPK and folate-methionine cycle signalling, improving glucose utilisation.
Storage — lyophilised
Refrigerate 2-8C, protect from light.
Storage — reconstituted
Refrigerate 2-8C, use within ~28 days.
Reconstitution notes
Add 2 ml bacteriostatic water to a 10 mg vial for 50 mcg per unit.
Commonly stacked with
- NAD+
- 5-Amino-1MQ
Commonly reported side effects
- Fatigue
- Flushing
- Injection-site irritation
Contraindications noted
- Pregnancy or breastfeeding
Research notes
Human data very limited; mostly mouse metabolic studies.
Track this properly
Work out syringe units with the free calculator, or set up a full schedule in about a minute.
Reference information only, not medical advice. See our medical disclaimer.